Differences between Human and Rat Intestinal and Hepatic Bisphenol A Glucuronidation and the Influence of Alamethicin on In Vitro Kinetic Measurements

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Drug Metabolism And Disposition

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1124/dmd.110.034819PMID 20736320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessing Risks from Bisphenol A

  2010cited by this paper
• Bisphenol A levels in blood depend on age and exposure.

  2009cited by this paper
• Bisphenol A may reduce the efficacy of androgen deprivation therapy in prostate cancer

  2009cited by this paper
• Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes

  2009cited by this paper
• Contrasting Influence of NADPH and a NADPH-Regenerating System on the Metabolism of Carbonyl-Containing Compounds in Hepatic Microsomes

  2009cited by this paper
• Relative Importance of Intestinal and Hepatic Glucuronidation—Impact on the Prediction of Drug Clearance

  2009cited by this paper
• Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.

  2008cited by this paper
• Characterization of 1′-Hydroxymidazolam Glucuronidation in Human Liver Microsomess⃞

  2008influential reference
• Predicting Plasma Concentrations of Bisphenol A in Children Younger Than 2 Years of Age after Typical Feeding Schedules, using a Physiologically Based Toxicokinetic Model

  2008cited by this paper
• In vitro methods to study intestinal drug metabolism.

  2007influential reference
• Prediction of Metabolic Clearance of Bisphenol A (4,4 ′-Dihydroxy-2,2-diphenylpropane) using Cryopreserved Human Hepatocytes

  2007influential reference
• Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

  2007cited by this paper
• Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans.

  2007cited by this paper
• QUANTITATION OF BISPHENOL A AND BISPHENOL A GLUCURONIDE IN BIOLOGICAL SAMPLES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY

  2005cited by this paper
• Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach.

  2005cited by this paper
• Gender difference in serum bisphenol A levels may be caused by liver UDP-glucuronosyltransferase activity in rats.

  2004cited by this paper
• Identification of human UDP‐glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3‐hydroxydesloratadine

  2004cited by this paper
• Comparison of the Use of Liver Models for Predicting Drug Clearance Using in Vitro Kinetic Data from Hepatic Microsomes and Isolated Hepatocytes

  2004cited by this paper
• Bisphenol A glucuronidation and absorption in rat intestine.

  2003cited by this paper
• Stereochemical aspects of carbonyl reduction of the original anticancer drug oracin by mouse liver microsomes and purified 11beta-hydroxysteroid dehydrogenase type 1.

  2003cited by this paper
• The small intestine as a xenobiotic-metabolizing organ.

  2003cited by this paper
• Complexities of glucuronidation affecting in vitro in vivo extrapolation.

  2002cited by this paper
• Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels.

  2002cited by this paper
• Metabolism of bisphenol a in primary cultured hepatocytes from mice, rats, and humans.

  2002cited by this paper
• Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein

  2002cited by this paper
• Excretion of bisphenol A-glucuronide into the small intestine and deconjugation in the cecum of the rat.

  2002cited by this paper
• Metabolism and kinetics of bisphenol a in humans at low doses following oral administration.

  2002cited by this paper
• The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.

  2002cited by this paper
• The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†

  2001cited by this paper
• Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans.

  2001cited by this paper
• The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration.

  2000cited by this paper
• In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.

  2000cited by this paper
• Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDP-glucuronosyltransferase, UGT2B1, in the rat liver.

  1999cited by this paper
• Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices.

  1997cited by this paper
• Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.

  1997cited by this paper
• Metabolism and Kinetics

  1988influential reference

• Isomer-specific metabolism and novel metabolite identification of bisphenol A and its isomer o, p'-BPA in humans.

  2026cites this paper
• Human Internal Exposures of Bisphenol A and Six Data-Poor Analogs Predicted by Physiologically Based Kinetic Models with Multimodal Parametrization

  2025cites this paper
• Derivation of a Human In Vivo Benchmark Dose for Bisphenol A from ToxCast In Vitro Concentration Response Data Using a Computational Workflow for Probabilistic Quantitative In Vitro to In Vivo Extrapolation

  2022cites this paper
• Genotoxic potential of bisphenol A: A review.

  2022cites this paper
• Sex-specific effects of bisphenol A on the signaling pathway of ESRRG in the human placenta

  2022cites this paper
• Impact of in vitro experimental variation in kinetic parameters on physiologically based kinetic (PBK) model simulations.

  2022influential citation
• The effects of bisphenols on the cardiovascular system

  2022cites this paper
• The toxicokinetics of bisphenol A and its metabolites in fish elucidated by a PBTK model.

  2022cites this paper
• Considerations for Improving Metabolism Predictions for In Vitro to In Vivo Extrapolation

  2022influential citation
• Mechanistic Study on the Species Differences in Excretion Pathway of HR011303 in Humans and Rats

  2021cites this paper
• Polycarbonate Plastics and Neurological Disorders: From Exposure to Preventive Interventions

  2021cites this paper
• Comprehensive in vitro metabolism study of bisphenol A using liquid chromatography-high resolution tandem mass spectrometry.

  2020cites this paper
• Bisphenols Threaten Male Reproductive Health via Testicular Cells

  2020cites this paper
• In vitro glucuronidation of bisphenol A in liver and intestinal microsomes: interspecies differences in humans and laboratory animals

  2020influential citation
• Toxicokinetics of bisphenol-S and its glucuronide in plasma and urine following oral and dermal exposure in volunteers for the interpretation of biomonitoring data.

  2020cites this paper
• Neurochemical characterization of the enteric neurons within the porcine jejunum in physiological conditions and under the influence of bisphenol A (BPA)

  2019cites this paper
• Endocrine disruptors and ovine reproductive development

  2019cites this paper
• Bisphenol A in Odontology: Recent data

  2019cites this paper
• Consumer Exposure to Bisphenolic Compounds: Advancing Exposure and Pharmacokinetic Modeling

  2019cites this paper
• The development of a pregnancy PBPK Model for Bisphenol A and its evaluation with the available biomonitoring data.

  2018cites this paper
• Bisphenol A: Food Exposure and Impact on Human Health.

  2018cites this paper
• Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes

  2018influential citation
• In vitro percutaneous absorption and metabolism of Bisphenol A (BPA) through fresh human skin.

  2018cites this paper
• Influence of gastrointestinal tract on metabolism of bisphenol A as determined by in vitro simulated system.

  2018cites this paper
• Human UGT2B7 is the major isoform responsible for the glucuronidation of clopidogrel carboxylate

  2018cites this paper
• Nitric oxide as an active substance in the enteric neurons of the porcine digestive tract in physiological conditions and under intoxication with bisphenol A (BPA).

  2018cites this paper
• Toxicity and Risk Assessment of Bisphenol A

  2017cites this paper
• Is bisphenol A an environmental obesogen?

  2017cites this paper
• Alamethicin for using in bioavailability studies? - Re-evaluation of its effect.

  2017cites this paper
• Toxicocinétique en santé environnementale : application à la mesure de l'exposition aux perturbateurs endocriniens

  2016cites this paper
• Bisphenol A and its analogs: Do their metabolites have endocrine activity?

  2016cites this paper
• Influence of Bisphenol A on Type 2 Diabetes Mellitus

  2016cites this paper
• Bisphenol A inhibits duodenal movement ex vivo of rat through nitric oxide‐mediated soluble guanylyl cyclase and α‐adrenergic signaling pathways

  2016cites this paper
• Bisphenol A and its analogs: Do their metabolites have endocrine activity?

  2016cites this paper
• Interactions métaboliques entre le bisphénol A et le naproxène dans un modèle de foie de rat isolé et perfusé

  2016cites this paper
• Opinion on the risks to public health related to the presence of bisphenol A ( BPA ) in foodstuffs : Executive summary

  2015influential citation
• Conjugation and Deconjugation Reactions within the Fetoplacental Compartment in a Sheep Model: A Key Factor Determining Bisphenol A Fetal Exposure

  2015influential citation
• Evaluation of four human cell lines with distinct biotransformation properties for genotoxic screening.

  2015cites this paper
• Conjugation and deconjugation reactions within the feto-placental compartment in a sheep model: a key factor determining bisphenol A fetal exposure

  2015influential citation
• Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells

  2015cites this paper
• Allometric scaling for predicting human clearance of bisphenol A.

  2015cites this paper
• Unraveling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling

  2015cites this paper
• Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A.

  2015cites this paper
• Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs

  2015cites this paper
• Complementarity of phosphorylated histones H2AX and H3 quantification in different cell lines for genotoxicity screening

  2015cites this paper
• Should oral gavage be abandoned in toxicity testing of endocrine disruptors?

  2014cites this paper
• The use of mode of action information in risk assessment: Quantitative key events/dose-response framework for modeling the dose-response for key events

  2014influential citation
• Oxidative and Hormonal Disruptions Underlie Bisphenol A: Induced Testicular Toxicity in Male Rabbits

  2014cites this paper
• The effects of genetics, epigenetics and obesity on ugt enzyme expression, activity and modeled hepatic clearance

  2014cites this paper
• Role of nuclear factor E2 related factor 2 (Nrf2) in development of steatosis and drug transporter alterations

  2013cites this paper
• Effect of combining in vitro estrogenicity data with kinetic characteristics of estrogenic compounds on the in vivo predictive value.

  2013influential citation
• Bisphenol A: Update on newly developed data and how they address NTP's 2008 finding of "Some Concern".

  2013cites this paper
• Prediction and evaluation of route dependent dosimetry of BPA in rats at different life stages using a physiologically based pharmacokinetic model.

  2013influential citation
• Functional UDP-glucuronyltransferase 2B15 polymorphism and bisphenol A concentrations in blood: results from physiologically based kinetic modelling

  2013cites this paper
• The effect of obesity on UGT enzyme expression, activity and modeled hepatic clearance by glucuronidation

  2013cites this paper
• Recent Results in Alamethicin Research

  2013cites this paper
• Effect of Metabolic Disease and Xenobiotic Exposure on Hepatic ATP-Binding Cassette (ABC) Drug Transporter Expression

  2013cites this paper
• Développement d’une approche toxicocinétique/toxicodynamique basée sur des mécanismes physiologiques pour évaluer les effets oestrogéniques du Bisphénol A

  2012cites this paper
• Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results

  2012cites this paper
• Automatable microplate-based in vitro assays for screening intestinal drug transport and metabolism

  2012cites this paper
• Differential Effects of Bisphenol A and Diethylstilbestrol on Human, Rat and Mouse Fetal Leydig Cell Function

  2012cites this paper
• The fetal programming of dietary fructose and saturated fat on hepatic quercetin glucuronidation in rats

  2012cites this paper
• Human and rat ABC transporter efflux of bisphenol a and bisphenol a glucuronide: interspecies comparison and implications for pharmacokinetic assessment.

  2012cites this paper
• Evaluation of bisphenol A glucuronidation according to UGT1A1*28 polymorphism by a new LC-MS/MS assay.

  2012cites this paper
• A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.

  2012cites this paper
• Extrahepatic Drug-Metabolizing Enzymes and Their Significance

  2012cites this paper
• Endocrine Disruptors: Passage and Actions in Human Placenta

  2012cites this paper
• BISPHENOL A AND ITS POTENTIAL TOXIC EFFECTS ON LIVING ORGANISMS

  2012cites this paper
• Committee for Risk Assessment (RAC) Committee for Socio-economic Analysis (SEAC)

  2011cites this paper
• The contribution of dermal exposure to the internal exposure of bisphenol A in man.

  2011cites this paper
• Use of the γH2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines

  2011cites this paper
• Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A

  2011cites this paper
• Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans.

  2011influential citation
• Comparative Use of Isolated Hepatocytes and Hepatic Microsomes for Cytochrome P450 Inhibition Studies: Transporter-Enzyme Interplay

  2010cites this paper